Global Information
회사소개 | 문의 | 비교리스트

인간 생식 기술 시장 : 기술별, 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027년)

Human Reproductive Technologies Market, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 06월 상품 코드 948360
페이지 정보 영문
가격
US $ 4,500 ₩ 5,304,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,251,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,788,000 PPT Turned PDF (Enterprise User License)


인간 생식 기술 시장 : 기술별, 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027년) Human Reproductive Technologies Market, By Technology, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 06월 페이지 정보 : 영문

인간 생식 기술은 임신이나 불임 문제에 대응하는 것으로, 보조생식기술(ART), 예후, 피임, 동성 생식 등이 포함됩니다. ART는 인공 수정, 인공 생식, 클로닝, 세포질 이식, 불임 치료, 호르몬 치료 등을 이용해 저수태나 불임 치료를 지원하는 기술입니다.

세계의 인간 생식 기술 시장을 조사했으며, 시장 역학과 규제, 동향 분석, 기술별, 지역별 분석, 경쟁 상황과 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

  • 보고서 개요
  • 시장 정의와 범위
  • 주요 요약
  • 기술별
  • 시장 기회 맵

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • 영향 분석
  • 주요 발전
  • 기술 진보
  • 규제 시나리오

제4장 시장 분석 : 기술별

  • 서론
  • 시장 점유율 분석
  • 전년대비 성장률 분석
  • 부문 동향
    • 불임약
    • 피임약과 피임구

제5장 시장 분석 : 지역별

  • 서론
  • 시장 점유율 분석
  • 전년대비 성장률 분석
  • 부문 동향
    • 북미
      • 미국
      • 캐나다
    • 유럽
      • 영국
      • 독일
      • 이탈리아
      • 프랑스
      • 스페인
      • 러시아
      • 기타
    • 아시아태평양
      • 중국
      • 인도
      • 일본
      • ASEAN
      • 호주
      • 한국
      • 기타
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 아르헨티나
      • 기타
    • 중동
      • GCC
      • 이스라엘
      • 기타
    • 아프리카
      • 북아프리카
      • 중앙아프리카
      • 남아프리카

제6장 경쟁 상황

  • 기업 개요
  • Abbott Laboratories
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Evofem Biosciences, Inc.
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Actavis Generics(Teva Pharmaceutical Industries Ltd.)
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Sun Pharmaceutical Industries Ltd.
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Perrigo Company plc
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Uniprix
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Gavis Pharmaceuticals(Lupin Limited)
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Sandoz International GmbH
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Aurobindo Pharma Limited
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • HRA Pharma, SA
  • 기업 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • 기타 주요 기업

제7장 섹션

  • 참고문헌
  • 조사 방법
KSM 20.07.29

Title:
Human Reproductive Technologies Market, By Technology (Infertility Drugs, Contraceptive Drugs and Devices), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Human reproductive technologies assist parents who are having troubles in pregnancies, and infertility issues. These technologies include Assisted Reproductive Technology (ART), prognostics, contraception, and same-sex procreation. ART aids in the treatment of low fertility or infertility using artificial insemination, artificial reproduction, cloning, cytoplasmic transfer, fertility medication, hormone treatment, and others.

Restraints of the Global Human Reproductive Technologies Market

Major factors hampering the growth of the human reproductive technologies market during the forecast period constitutes of limited insurance coverage for ART, and low adoption of emergency human reproductive technologies in emerging economies.

Key features of the study:

  • This report provides in-depth analysis of the global human reproductive technologies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global human reproductive technologies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Cryos USA, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., Pantarhei Bioscience B.V., Cook Medical, Inc., Ferring Pharmaceuticals, Johnson & Johnson, Dare Bioscience, Inc., and Merck Serono.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global human reproductive technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Human Reproductive Technologies Market, By Technology:
    • Infertility Drugs
    • Contraceptive Drugs and Devices
  • Global Human Reproductive Technologies Market, By Geography:
    • North America
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • U.S.
  • Canada
    • Europe
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
    • Asia Pacific
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
    • Latin America
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • Middle East:
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • Africa
    • By Technology
  • Infertility Drugs
  • Contraceptive Drugs and Devices
    • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
    • Abbott Laboratories*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
    • Evofem Biosciences, Inc.
    • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
    • Sun Pharmaceutical Industries Ltd.
    • Perrigo Company plc
    • Uniprix
    • Gavis Pharmaceuticals (Lupin Limited)
    • Sandoz International GmbH
    • Aurobindo Pharma Limited
    • HRA Pharma, SA
    • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Technology
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Human Reproductive Technologies Market, By Technology, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Infertility Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Contraceptive Drugs and Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Human Reproductive Technologies Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Evofem Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Actavis Generics (Teva Pharmaceutical Industries Ltd.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Perrigo Company plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Uniprix
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Gavis Pharmaceuticals (Lupin Limited)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Sandoz International GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aurobindo Pharma Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • HRA Pharma, SA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top
전화 문의
F A Q